Industry
Life Sciences
- California United States
- France Europe
- Ireland Europe
- New Jersey United States
- Pennsylvania United States
- South Korea Northeast Asia
- Texas United States
Scientific medical discovery holds the power to improve and extend lives, but translating that discovery into medicine requires deep expertise across every stage of development and production. SK invests in companies advancing both pharmaceutical innovation and the supply chain infrastructure that brings new treatments to patients.
SK companies bring decades of experience in researching and developing new medicines to improve patient lives. SK's portfolio includes leading pharmaceutical companies and contract development and manufacturing organizations (CDMOs) that help other companies analyze, develop, and produce treatments. SK companies play an important role at every stage of the pharma supply chain.